# OnCo record nct07007728 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07007728/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07007728", "NCT07007728" ;
  schema:name "Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis"@en ;
  schema:description "A phase 2 trial of bevacizumab (glioblastoma use) and cAPOX (capecitabine, oxaliplatin) in colorectal cancer, run by Peking University Cancer Hospital & Institute, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07007728/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07007728> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/thermal-ablation/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab-glioma/>, <https://onco.cc/drugs/capox/> .